Initiating early Antiretroviral treatment (ART) might lead to greater bone loss in patients with HIV, when compared with delayed ART.

TOP INSIGHT
Antiretroviral treatment (ART) are medications that treat HIV and when taken in combination can prevent the growth of the virus.
It will be important to understand the long-term consequences of reductions in bone mineral density associated with ART and whether these reductions continue or stabilise with longer therapy.
"What we found was that starting treatment is also associated with accelerated bone loss of about 2-4%, and the rate of decline then appears to slow after the first 2 years of treatment, compared with HIV positive people who deferred treatment," said Prof.
Jennifer Hoy, lead author of the Journal of Bone and Mineral Research study.
"We have no cure for HIV, so antiretroviral treatment is for life. An increased rate of bone loss may become important years later, in the setting of increased risk of fragility fracture."
Source-Eurekalert
MEDINDIA



Email









